466 related articles for article (PubMed ID: 26205635)
1. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.
Tauhid S; Chu R; Sasane R; Glanz BI; Neema M; Miller JR; Kim G; Signorovitch JE; Healy BC; Chitnis T; Weiner HL; Bakshi R
J Neurol; 2015 Nov; 262(11):2425-32. PubMed ID: 26205635
[TBL] [Abstract][Full Text] [Related]
2. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
[TBL] [Abstract][Full Text] [Related]
3. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.
Bakshi R; Neema M; Healy BC; Liptak Z; Betensky RA; Buckle GJ; Gauthier SA; Stankiewicz J; Meier D; Egorova S; Arora A; Guss ZD; Glanz B; Khoury SJ; Guttmann CR; Weiner HL
Arch Neurol; 2008 Nov; 65(11):1449-53. PubMed ID: 19001162
[TBL] [Abstract][Full Text] [Related]
4. An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.
Kim G; Tauhid S; Dupuy SL; Tummala S; Khalid F; Healy BC; Bakshi R
J Neurol; 2016 Mar; 263(3):531-8. PubMed ID: 26754005
[TBL] [Abstract][Full Text] [Related]
5. Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis.
Khalid F; Healy BC; Dupuy SL; Chu R; Chitnis T; Bakshi R; Houtchens M
J Neurol Sci; 2018 Sep; 392():94-99. PubMed ID: 30031994
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
8. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
[TBL] [Abstract][Full Text] [Related]
9. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening.
Janardhan V; Suri S; Bakshi R
Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319
[TBL] [Abstract][Full Text] [Related]
12. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.
Sanfilipo MP; Benedict RH; Sharma J; Weinstock-Guttman B; Bakshi R
Neuroimage; 2005 Jul; 26(4):1068-77. PubMed ID: 15961046
[TBL] [Abstract][Full Text] [Related]
13. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.
Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R
J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095
[TBL] [Abstract][Full Text] [Related]
14. Employment and absenteeism in working-age persons with multiple sclerosis.
Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
[TBL] [Abstract][Full Text] [Related]
15. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings.
Kimiskidis VK; Papaliagkas V; Sotirakoglou K; Kouvatsou ZK; Kapina VK; Papadaki E; Tsimourtou V; Masoura E; Kazis DA; Papayiannopoulos S; Geroukis T; Bostanjopoulou S
Mult Scler Relat Disord; 2016 Nov; 10():192-197. PubMed ID: 27919489
[TBL] [Abstract][Full Text] [Related]
16. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
[TBL] [Abstract][Full Text] [Related]
17. MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a.
Gasperini C; Paolillo A; Giugni E; Galgani S; Bagnato F; Mainero C; Onesti E; Bastianello S; Pozzilli C
Mult Scler; 2002 Apr; 8(2):119-23. PubMed ID: 11990868
[TBL] [Abstract][Full Text] [Related]
18. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
[TBL] [Abstract][Full Text] [Related]
19. Exploring the effect of glatiramer acetate on cerebral gray matter atrophy in multiple sclerosis.
AbdelRazek MA; Tummala S; Khalid F; Tauhid S; Jalkh Y; Khalil S; Hurwitz S; Zurawski J; Bakshi R
J Neurol Sci; 2023 Jan; 444():120501. PubMed ID: 36481574
[TBL] [Abstract][Full Text] [Related]
20. Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue.
Kalkers NF; Vrenken H; Uitdehaag BM; Polman CH; Barkhof F
Mult Scler; 2002 Oct; 8(5):410-4. PubMed ID: 12356208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
